Interim safety analysis of cancer immunotherapy trials Network – 12 (CITN-12): a Phase 1 study of pembrolizumab in patients with HIV and cancer
Titel:
Interim safety analysis of cancer immunotherapy trials Network – 12 (CITN-12): a Phase 1 study of pembrolizumab in patients with HIV and cancer
Auteur:
Uldrick, T.S. ‘Mac’ Cheever, M.A. Gonçalves, P.H. Fling, S. Aleman, K. Emu, B. Ernstoff, M.S. Gorelick, R. Kaiser, J. E Kohrt, H. Lacroix, A. Lindsley, M. M Lundgren, L. Lurain, K. Maldarelli, F. Parsons, C. Sharon, E. Widell, A. Yarchoan, R.